TEBENTAFUSP-TEBN for Choroid melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where TEBENTAFUSP-TEBN was used for Choroid melanoma.
Most Reported Side Effects for TEBENTAFUSP-TEBN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 63 | 18.0% | 7 | 32 |
| Cytokine release syndrome | 59 | 16.9% | 11 | 26 |
| Hypotension | 47 | 13.4% | 7 | 33 |
| Rash | 43 | 12.3% | 2 | 21 |
| Disease progression | 42 | 12.0% | 9 | 6 |
| Chills | 38 | 10.9% | 4 | 21 |
| Product dose omission issue | 37 | 10.6% | 0 | 11 |
| Malignant neoplasm progression | 32 | 9.1% | 3 | 4 |
| Nausea | 29 | 8.3% | 2 | 12 |
| Vomiting | 22 | 6.3% | 1 | 13 |
| Pruritus | 21 | 6.0% | 0 | 14 |
| Death | 17 | 4.9% | 17 | 4 |
| Fatigue | 15 | 4.3% | 1 | 6 |
| Asthenia | 12 | 3.4% | 4 | 9 |
| Hypoxia | 12 | 3.4% | 3 | 7 |
Other Indications for TEBENTAFUSP-TEBN
Product used for unknown indication (127)
Metastatic ocular melanoma (114)
Uveal melanoma (72)
Metastatic malignant melanoma (7)
Other Drugs Used for Choroid melanoma
IPILIMUMAB (46)
NIVOLUMAB (42)
PEMBROLIZUMAB (20)
RANIBIZUMAB (14)
TEBENTAFUSP (8)
BEVACIZUMAB (7)
FOTEMUSTINE (5)
SORAFENIB (5)